Guidelines For Preventing Sudden Cardiac Death Could Impact ICD Sales
This article was originally published in The Gray Sheet
Executive Summary
For the first time, physicians have access to comprehensive, widely endorsed guidelines for the prevention of sudden cardiac death - including clearer recommendations than ever before about when to treat various types of patients with implantable cardioverter defibrillators
You may also be interested in...
Study Questions Benefit Of ICDs In Dialysis Patients, Cites Need For Research
The benefit of implanting end-stage renal disease (ESRD) patients with defibrillators needs further evaluation, according to a study in the October issue of Heart Rhythm.
Medtronic To Cardiologists: Get With The Guidelines On ICD Use
Medtronic's effort to reignite growth of the implantable cardioverter defibrillator market includes its IMPROVE HF study to evaluate physician practices and promote adoption of established guidelines for ICD use
Study Questions Benefit Of ICDs In Dialysis Patients, Cites Need For Research
The benefit of implanting end-stage renal disease (ESRD) patients with defibrillators needs further evaluation, according to a study in the October issue of Heart Rhythm.